|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 9/00 | |||
| A61K 47/18 | |||
| A61K 47/26 |
| (11) | Number of the document | 2515941 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10798236.5 |
| Date of filing the European patent application | 2010-12-20 | |
| (97) | Date of publication of the European application | 2012-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/061347 |
| Date | 2010-12-20 |
| (87) | Number | WO 2011/084750 |
| Date | 2011-07-14 |
| (30) | Number | Date | Country code |
| 288535 P | 2009-12-21 | US |
| (72) |
GOKARN, Yatin, R., US
KAMERZELL, Timothy, J., US
LI, Megan, US
CROMWELL, Mary, US
LIU, Hong, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PHARMACEUTICAL FORMULATION OF BEVACIZUMAB |
| PHARMACEUTICAL FORMULATION OF BEVACIZUMAB |